Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Derm SAQs

Derm SAQs ·

Traction Alopecia — SAQ

Model SAQ on traction alopecia covering definition, classification, clinical features, differential diagnosis, and stepwise management with focus on the single most important intervention and the 'fringe sign'.

10 marks10 min3 min readVerification in progress
On this page
Study tools
Prompt
Model SAQ on traction alopecia covering definition, classification, clinical features, differential diagnosis, and stepwise management with focus on the single most important intervention and the 'fringe sign'.

Write your answer

Saved on this device. No marking — you are the marker.

Stem

A 28-year-old Black woman presents with a 5-year history of progressive frontal and temporal hairline recession. She has worn tight braids with glued-in extensions for 12 years and chemical-relaxes her hair every 6 weeks. On examination, the frontal and temporal hairline is receded with a smooth, shiny, atrophic appearance. There is a retained band of fine, short hairs along the very rim. No active erythema or pustules are seen. The occipital donor area is dense and uninvolved. A pull test is negative.

Questions

a) What is the most likely diagnosis, and which clinical sign confirms it? (2 marks)

  • Diagnosis: Late-stage (irreversible) marginal traction alopecia (biphasic mechanical → scarring hair loss from sustained tension).
[1]
  • The confirming clinical sign is the fringe sign (Samrao 2011) — a retained band of fine, short (vellus) hairs along the very frontal and/or temporal rim, with thinning immediately behind it. It is considered sensitive and specific for marginal traction alopecia and indicates that the marginal follicles are miniaturised but not yet destroyed.

[5]b) What are the key features in the history that establish the aetiology, and what risk factors are present? (2 marks)

  • Tight braids with glued-in extensions for 12 years; chemical relaxer every 6 weeks; high frequency of re-tightening; combined chemical + mechanical injury (the highest-risk pattern for traction alopecia and CCCA in women of African descent).
  • Establish the absence of pulling (to distinguish from trichotillomania), the hairstyle history, frequency, weight, pain on styling (Khumalo's warning sign), heat use, and family history of CCCA.

[2][4]c) What is the differential diagnosis, and how is this distinguished from frontal fibrosing alopecia (FFA) and trichotillomania? (3 marks)

[3]- Differential diagnosis includes alopecia areata, trichotillomania, telogen effluvium, frontal fibrosing alopecia, lichen planopilaris, androgenetic alopecia, and central centrifugal cicatricial alopecia (CCCA) on the traction spectrum.

  • Vs FFA: FFA is a lymphocytic cicatricial alopecia of POST-MENOPAUSAL women, with PERIFOLLICULAR ERYTHEMA, EYEBROW loss, and NO hairstyle history. Biopsy shows a lichenoid infiltrate at the isthmus. Traction alopecia is hairstyle-related, often in younger women, and retains the fringe.
  • Vs trichotillomania: Trichotillomania presents with IRREGULAR patches of BROKEN HAIRS OF VARYING LENGTHS ('Friar Tuck' or 'tonsure' sign), psychiatric comorbidity, and a history of PULLING rather than tight styling. The patch is not distributed along the vector of force.

[2]d) Outline your stepwise management plan, and state the single most important intervention. (2 marks)

  • The single most important intervention is to DISCONTINUE the traction-inducing hairstyle (and the chemical relaxer) and adopt loose, natural styles. In late-stage scarring disease this will not regrow hair but it will prevent further loss and is a pre-requisite for any future transplantation.
  • Adjuncts (layered on top of hairstyle change):
    • Topical minoxidil 2% (or 5%) twice daily to the affected margin for ≥ 6–12 months.
    • Topical corticosteroid lotion (mometasone furoate 0.1% or betamethasone dipropionate 0.05%) for any residual inflammation.
    • Cosmetic camouflage (wigs, hairpieces, scalp micropigmentation) for immediate psychosocial relief.
    • Hair transplantation (FUE or FUT) for definitive restoration, BUT only when the disease is BURNT-OUT (no active inflammation for ≥ 12 months), the occipital donor is intact (no CCCA), and the patient has realistic expectations (1–3 sessions over 18–24 months; 70–90% graft survival at 12 months in experienced hands).
  • Prevention: looser hairstyles, no chemicals on fragile hair, ≥ 4–6 weeks per year without traction, satin or silk sleep cap, no pain on styling.

[1]e) What is the prognosis, and what determines the outcome? (1 mark)

  • The disease is irreversible in its current state; follicles cannot regrow.
  • Outcome is determined by duration of traction, severity at presentation, adherence to hairstyle change, donor density, surgical expertise, and psychosocial support.
  • A full cosmetic result is achievable with FUE/FUT in 2–3 sessions in an experienced centre; without transplantation, the patient is left with permanent scarring alopecia, which can be camouflaged with wigs, hairpieces, or scalp micropigmentation.
References5ShowHide
  1. [1]Afifi L, Oparaugo NC, Hogeling M Review of traction alopecia in the pediatric patient: Diagnosis, prevention, and management Pediatr Dermatol, 2021.PMID 34467569
  2. [2]Haskin A, Aguh C All hairstyles are not created equal: What the dermatologist needs to know about black hairstyling practices and the risk of traction alopecia (TA) J Am Acad Dermatol, 2016.PMID 27114262
  3. [3]Afifi L, Oparaugo NC, Hogeling M Review of traction alopecia in the pediatric patient: Diagnosis, prevention, and management Pediatr Dermatol, 2021.PMID 34467569
  4. [4]Haskin A, Aguh C All hairstyles are not created equal: What the dermatologist needs to know about black hairstyling practices and the risk of traction alopecia (TA) J Am Acad Dermatol, 2016.PMID 27114262
  5. [5]Samrao A, Price VH, Zedek D, Mirmirani P The Fringe Sign - A useful clinical finding in traction alopecia of the marginal hair line Dermatol Online J, 2011.PMID 22136857
PreviousTopical Retinoids — SAQNextTreatment of facial erythema in patients with rosacea with topical brimonidine tartrate: correlation with patient satisfaction. — SAQ